The first Perspective Therapeutics trade was made in Q4 2019.
Since then Jim Simons bought shares seven more times and sold shares on eleven occasions. The investor completely sold their stake between Q3 2023 and Q2 2024.
Avg closing price
Price range
Sold -31.7 Thousand shares
Q2 2024
Avg closing price
-
Price range
-
-
-
Sold 89.7% shares (-275 Thousand shares)
Q1 2024
Avg closing price
-
Price range
-
-
-
Sold 16.6% shares (-60.9 Thousand shares)
Q4 2023
Avg closing price
-
Price range
-
-
-
Sold 15.9% shares (-69.3 Thousand shares)
Q3 2023
Avg closing price
-
Price range
-
-
-
Increased shares by 4.9% (+20.4 Thousand shares)
Q2 2023
Avg closing price
-
Price range
-
-
-
Increased shares by 9.9% (+37.4 Thousand shares)
Q1 2023
Avg closing price
$0.33
Price range
$0.24
-
$0.42
Increased shares by 1.9% (+7 Thousand shares)
Q4 2022
Avg closing price
$0.33
Price range
$0.24
-
$0.40
Sold 1.3% shares (-4.97 Thousand shares)
Q3 2022
Avg closing price
$0.34
Price range
$0.22
-
$0.43
Sold 9.6% shares (-40.2 Thousand shares)
Q2 2022
Avg closing price
$0.31
Price range
$0.26
-
$0.37
Sold 57.5% shares (-564 Thousand shares)
Q1 2022
Avg closing price
$0.36
Price range
$0.31
-
$0.41
Sold 17.8% shares (-213 Thousand shares)
Q4 2021
Avg closing price
$0.53
Price range
$0.38
-
$0.68
Sold 53.7% shares (-1.39 Million shares)
Q3 2021
Avg closing price
$0.68
Price range
$0.58
-
$0.79
Sold 20.9% shares (-680 Thousand shares)
Q2 2021
Avg closing price
$0.88
Price range
$0.75
-
$1.15
Increased shares by 141.8% (+1.91 Million shares)
Q1 2021
Avg closing price
$1.51
Price range
$0.53
-
$2.47
Increased shares by 164.1% (+838 Thousand shares)
Q4 2020
Avg closing price
$0.44
Price range
$0.36
-
$0.58
Sold 52.6% shares (-567 Thousand shares)
Q3 2020
Avg closing price
$0.65
Price range
$0.54
-
$0.78
Increased shares by 57.6% (+394 Thousand shares)
Q2 2020
Avg closing price
$0.64
Price range
$0.46
-
$0.86
Increased shares by 177.5% (+438 Thousand shares)
Q1 2020